메뉴 건너뛰기




Volumn 6, Issue 1, 2011, Pages

K70Q adds high-level tenofovir resistance to "Q151M complex" HIV reverse transcriptase through the enhanced discrimination mechanism

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ADENOSINE TRIPHOSPHATE; DIDANOSINE; DNA; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RECOMBINANT ENZYME; STAVUDINE; TENOFOVIR DISOPROXIL; ZIDOVUDINE; ADENINE; DRUG DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR;

EID: 79251583792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016242     Document Type: Article
Times cited : (31)

References (64)
  • 1
    • 0033165851 scopus 로고    scopus 로고
    • A mechanism of AZT resistance: An increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase
    • Meyer PR, Matsuura SE, Mian AM, So AG, Scott WA (1999) A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol Cell 4: 35-43.
    • (1999) Mol Cell , vol.4 , pp. 35-43
    • Meyer, P.R.1    Matsuura, S.E.2    Mian, A.M.3    So, A.G.4    Scott, W.A.5
  • 2
    • 0035031936 scopus 로고    scopus 로고
    • Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase
    • Boyer PL, Sarafianos SG, Arnold E, Hughes SH (2001) Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J Virol 75: 4832-4842.
    • (2001) J Virol , vol.75 , pp. 4832-4842
    • Boyer, P.L.1    Sarafianos, S.G.2    Arnold, E.3    Hughes, S.H.4
  • 3
    • 0032506055 scopus 로고    scopus 로고
    • Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase
    • Arion D, Kaushik N, McCormick S, Borkow G, Parniak MA (1998) Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 37: 15908-15917.
    • (1998) Biochemistry , vol.37 , pp. 15908-15917
    • Arion, D.1    Kaushik, N.2    McCormick, S.3    Borkow, G.4    Parniak, M.A.5
  • 4
    • 77955594846 scopus 로고    scopus 로고
    • Structural aspects of drug resistance and inhibition of HIV-1 reverse transcriptase
    • Singh K, Marchand B, Kirby KA, Michailidis E, Sarafianos SG (2010) Structural aspects of drug resistance and inhibition of HIV-1 reverse transcriptase. Viruses 2: 606-638.
    • (2010) Viruses , vol.2 , pp. 606-638
    • Singh, K.1    Marchand, B.2    Kirby, K.A.3    Michailidis, E.4    Sarafianos, S.G.5
  • 5
    • 0034329473 scopus 로고    scopus 로고
    • Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance
    • Mas A, Parera M, Briones C, Soriano V, Martinez MA, et al. (2000) Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance. EMBO J 19: 5752-5761.
    • (2000) EMBO J , vol.19 , pp. 5752-5761
    • Mas, A.1    Parera, M.2    Briones, C.3    Soriano, V.4    Martinez, M.A.5
  • 6
    • 2642518791 scopus 로고    scopus 로고
    • Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: Effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DNA primers
    • Matamoros T, Franco S, Vazquez-Alvarez BM, Mas A, Martinez MA, et al. (2004) Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DNA primers. J Biol Chem 279: 24569- 24577.
    • (2004) J Biol Chem , vol.279 , pp. 24569-24577
    • Matamoros, T.1    Franco, S.2    Vazquez-Alvarez, B.M.3    Mas, A.4    Martinez, M.A.5
  • 7
    • 0037334586 scopus 로고    scopus 로고
    • Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation
    • Meyer PR, Lennerstrand J, Matsuura SE, Larder BA, Scott WA (2003) Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation. J Virol 77: 3871-3877.
    • (2003) J Virol , vol.77 , pp. 3871-3877
    • Meyer, P.R.1    Lennerstrand, J.2    Matsuura, S.E.3    Larder, B.A.4    Scott, W.A.5
  • 8
    • 0032571005 scopus 로고    scopus 로고
    • Insertions into the beta3-beta4 hairpin loop of HIV-1 reverse transcriptase reveal a role for fingers subdomain in processive polymerization
    • Kew Y, Olsen LR, Japour AJ, Prasad VR (1998) Insertions into the beta3-beta4 hairpin loop of HIV-1 reverse transcriptase reveal a role for fingers subdomain in processive polymerization. J Biol Chem 273: 7529-7537.
    • (1998) J Biol Chem , vol.273 , pp. 7529-7537
    • Kew, Y.1    Olsen, L.R.2    Japour, A.J.3    Prasad, V.R.4
  • 9
    • 0036720770 scopus 로고    scopus 로고
    • Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision
    • Boyer PL, Sarafianos SG, Arnold E, Hughes SH (2002) Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision. J Virol 76: 9143-9151.
    • (2002) J Virol , vol.76 , pp. 9143-9151
    • Boyer, P.L.1    Sarafianos, S.G.2    Arnold, E.3    Hughes, S.H.4
  • 10
    • 43049105858 scopus 로고    scopus 로고
    • Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase
    • Menendez-Arias L (2008) Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase. Virus Res 134: 124-146.
    • (2008) Virus Res , vol.134 , pp. 124-146
    • Menendez-Arias, L.1
  • 11
    • 58149133507 scopus 로고    scopus 로고
    • Structure and function of HIV-1 reverse transcriptase: Molecular mechanisms of polymerization and inhibition
    • Sarafianos SG, Marchand B, Das K, Himmel DM, Parniak MA, et al. (2009) Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J Mol Biol 385: 693-713.
    • (2009) J Mol Biol , vol.385 , pp. 693-713
    • Sarafianos, S.G.1    Marchand, B.2    Das, K.3    Himmel, D.M.4    Parniak, M.A.5
  • 12
    • 0033621167 scopus 로고    scopus 로고
    • Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with betabranched amino acids
    • Sarafianos SG, Das K, Clark AD, Jr., Ding J, Boyer PL, et al. (1999) Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with betabranched amino acids. Proc Natl Acad Sci U S A 96: 10027-10032.
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 10027-10032
    • Sarafianos, S.G.1    Das, K.2    Clark Jr., A.D.3    Ding, J.4    Boyer, P.L.5
  • 13
    • 0034616958 scopus 로고    scopus 로고
    • The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase
    • Gao HQ, Boyer PL, Sarafianos SG, Arnold E, Hughes SH (2000) The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase. J Mol Biol 300: 403-418.
    • (2000) J Mol Biol , vol.300 , pp. 403-418
    • Gao, H.Q.1    Boyer, P.L.2    Sarafianos, S.G.3    Arnold, E.4    Hughes, S.H.5
  • 14
    • 0028273314 scopus 로고
    • Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations
    • Shafer RW, Kozal MJ, Winters MA, Iversen AK, Katzenstein DA, et al. (1994) Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. J Infect Dis 169: 722-729.
    • (1994) J Infect Dis , vol.169 , pp. 722-729
    • Shafer, R.W.1    Kozal, M.J.2    Winters, M.A.3    Iversen, A.K.4    Katzenstein, D.A.5
  • 15
    • 0028940084 scopus 로고
    • Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides
    • Shirasaka T, Kavlick MF, Ueno T, Gao WY, Kojima E, et al. (1995) Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc Natl Acad Sci U S A 92: 2398-2402.
    • (1995) Proc Natl Acad Sci U S A , vol.92 , pp. 2398-2402
    • Shirasaka, T.1    Kavlick, M.F.2    Ueno, T.3    Gao, W.Y.4    Kojima, E.5
  • 16
    • 0030048748 scopus 로고    scopus 로고
    • Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy
    • Iversen AK, Shafer RW, Wehrly K, Winters MA, Mullins JI, et al. (1996) Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J Virol 70: 1086-1090.
    • (1996) J Virol , vol.70 , pp. 1086-1090
    • Iversen, A.K.1    Shafer, R.W.2    Wehrly, K.3    Winters, M.A.4    Mullins, J.I.5
  • 17
    • 0031948662 scopus 로고    scopus 로고
    • Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance
    • Maeda Y, Venzon DJ, Mitsuya H (1998) Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance. J Infect Dis 177: 1207-1213.
    • (1998) J Infect Dis , vol.177 , pp. 1207-1213
    • Maeda, Y.1    Venzon, D.J.2    Mitsuya, H.3
  • 18
    • 0037867659 scopus 로고    scopus 로고
    • Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variants
    • Matsumi S, Kosalaraksa P, Tsang H, Kavlick MF, Harada S, et al. (2003) Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variants. AIDS 17: 1127-1137.
    • (2003) AIDS , vol.17 , pp. 1127-1137
    • Matsumi, S.1    Kosalaraksa, P.2    Tsang, H.3    Kavlick, M.F.4    Harada, S.5
  • 19
    • 0033064963 scopus 로고    scopus 로고
    • Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an In vitro competitive HIV-1 replication assay
    • Kosalaraksa P, Kavlick MF, Maroun V, Le R, Mitsuya H (1999) Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an In vitro competitive HIV-1 replication assay. J Virol 73: 5356-5363.
    • (1999) J Virol , vol.73 , pp. 5356-5363
    • Kosalaraksa, P.1    Kavlick, M.F.2    Maroun, V.3    Le, R.4    Mitsuya, H.5
  • 20
    • 0033039932 scopus 로고    scopus 로고
    • A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC)
    • Garcia Lerma J, Schinazi RF, Juodawlkis AS, Soriano V, Lin Y, et al. (1999) A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC). Antimicrob Agents Chemother 43: 264-270.
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 264-270
    • Garcia, L.J.1    Schinazi, R.F.2    Juodawlkis, A.S.3    Soriano, V.4    Lin, Y.5
  • 21
    • 19344365422 scopus 로고    scopus 로고
    • Effects of HIV Q151M-associated multi-drug resistance mutations on the activities of (-)-beta- D-19,39-dioxolan guanine
    • Feng JY, Myrick F, Selmi B, Deval J, Canard B, et al. (2005) Effects of HIV Q151M-associated multi-drug resistance mutations on the activities of (-)-beta- D-19,39-dioxolan guanine. Antiviral Res 66: 153-158.
    • (2005) Antiviral Res , vol.66 , pp. 153-158
    • Feng, J.Y.1    Myrick, F.2    Selmi, B.3    Deval, J.4    Canard, B.5
  • 23
    • 37849043631 scopus 로고    scopus 로고
    • Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro
    • Smith RA, Gottlieb GS, Anderson DJ, Pyrak CL, Preston BD (2008) Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro. Antimicrob Agents Chemother 52: 329-332.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 329-332
    • Smith, R.A.1    Gottlieb, G.S.2    Anderson, D.J.3    Pyrak, C.L.4    Preston, B.D.5
  • 24
    • 0028784434 scopus 로고
    • Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'- dideoxynucleoside 5'-triphosphates
    • Ueno T, Shirasaka T, Mitsuya H (1995) Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'- dideoxynucleoside 5'-triphosphates. J Biol Chem 270: 23605-23611.
    • (1995) J Biol Chem , vol.270 , pp. 23605-23611
    • Ueno, T.1    Shirasaka, T.2    Mitsuya, H.3
  • 25
    • 0036829992 scopus 로고    scopus 로고
    • The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues
    • Deval J, Selmi B, Boretto J, Egloff MP, Guerreiro C, et al. (2002) The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues. J Biol Chem 277: 42097-42104.
    • (2002) J Biol Chem , vol.277 , pp. 42097-42104
    • Deval, J.1    Selmi, B.2    Boretto, J.3    Egloff, M.P.4    Guerreiro, C.5
  • 26
    • 0032573488 scopus 로고    scopus 로고
    • Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance
    • Huang H, Chopra R, Verdine GL, Harrison SC (1998) Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282: 1669-1675.
    • (1998) Science , vol.282 , pp. 1669-1675
    • Huang, H.1    Chopra, R.2    Verdine, G.L.3    Harrison, S.C.4
  • 27
    • 9944232661 scopus 로고    scopus 로고
    • Taking aim at a moving target: Designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases
    • Sarafianos SG, Das K, Hughes SH, Arnold E (2004) Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases. Curr Opin Struct Biol 14: 716-730.
    • (2004) Curr Opin Struct Biol , vol.14 , pp. 716-730
    • Sarafianos, S.G.1    Das, K.2    Hughes, S.H.3    Arnold, E.4
  • 28
    • 0028034266 scopus 로고
    • The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2', 3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro
    • Gu Z, Fletcher RS, Arts EJ, Wainberg MA, Parniak MA (1994) The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2', 3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro. J Biol Chem 269: 28118-28122.
    • (1994) J Biol Chem , vol.269 , pp. 28118-28122
    • Gu, Z.1    Fletcher, R.S.2    Arts, E.J.3    Wainberg, M.A.4    Parniak, M.A.5
  • 29
    • 0030892246 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years
    • Winters MA, Shafer RW, Jellinger RA, Mamtora G, Gingeras T, et al. (1997) Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years. Antimicrob Agents Chemother 41: 757-762.
    • (1997) Antimicrob Agents Chemother , vol.41 , pp. 757-762
    • Winters, M.A.1    Shafer, R.W.2    Jellinger, R.A.3    Mamtora, G.4    Gingeras, T.5
  • 30
    • 0034088720 scopus 로고    scopus 로고
    • Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group
    • Harrigan PR, Stone C, Griffin P, Najera I, Bloor S, et al. (2000) Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group. J Infect Dis 181: 912-920.
    • (2000) J Infect Dis , vol.181 , pp. 912-920
    • Harrigan, P.R.1    Stone, C.2    Griffin, P.3    Najera, I.4    Bloor, S.5
  • 31
    • 0037076708 scopus 로고    scopus 로고
    • Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF
    • Margot NA, Isaacson E, McGowan I, Cheng AK, Schooley RT, et al. (2002) Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF. AIDS 16: 1227-1235.
    • (2002) AIDS , vol.16 , pp. 1227-1235
    • Margot, N.A.1    Isaacson, E.2    McGowan, I.3    Cheng, A.K.4    Schooley, R.T.5
  • 32
    • 0034657706 scopus 로고    scopus 로고
    • Mutational analysis of Lys65 of HIV-1 reverse transcriptase
    • Sluis-Cremer N, Arion D, Kaushik N, Lim H, Parniak MA (2000) Mutational analysis of Lys65 of HIV-1 reverse transcriptase. Biochem J 348 Pt 1: 77-82.
    • (2000) Biochem J , vol.348 , Issue.PART 1 , pp. 77-82
    • Sluis-Cremer, N.1    Arion, D.2    Kaushik, N.3    Lim, H.4    Parniak, M.A.5
  • 33
    • 2942616457 scopus 로고    scopus 로고
    • A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions
    • Deval J, Navarro JM, Selmi B, Courcambeck J, Boretto J, et al. (2004) A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions. J Biol Chem 279: 25489-25496.
    • (2004) J Biol Chem , vol.279 , pp. 25489-25496
    • Deval, J.1    Navarro, J.M.2    Selmi, B.3    Courcambeck, J.4    Boretto, J.5
  • 34
    • 33644791590 scopus 로고    scopus 로고
    • Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine
    • Feng JY, Myrick FT, Margot NA, Mulamba GB, Rimsky L, et al. (2006) Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine. Nucleosides Nucleotides Nucleic Acids 25: 89-107.
    • (2006) Nucleosides Nucleotides Nucleic Acids , vol.25 , pp. 89-107
    • Feng, J.Y.1    Myrick, F.T.2    Margot, N.A.3    Mulamba, G.B.4    Rimsky, L.5
  • 35
    • 71749100912 scopus 로고    scopus 로고
    • Structural basis for the role of the K65r mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance
    • Das K, Bandwar RP, White KL, Feng JY, Sarafianos SG, et al. (2009) Structural basis for the role of the K65r mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. J Biol Chem 284: 35092-35100.
    • (2009) J Biol Chem , vol.284 , pp. 35092-35100
    • Das, K.1    Bandwar, R.P.2    White, K.L.3    Feng, J.Y.4    Sarafianos, S.G.5
  • 36
    • 0037326980 scopus 로고    scopus 로고
    • The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1
    • McColl DJ, Miller MD (2003) The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1. J Antimicrob Chemother 51: 219-223.
    • (2003) J Antimicrob Chemother , vol.51 , pp. 219-223
    • McColl, D.J.1    Miller, M.D.2
  • 37
    • 34147179893 scopus 로고    scopus 로고
    • Long-term follow-up of patients taking tenofovir DF with low-level HIV-1 viremia and the K65R substitution in HIV-1 RT
    • Chappell BJ, Margot NA, Miller MD (2007) Long-term follow-up of patients taking tenofovir DF with low-level HIV-1 viremia and the K65R substitution in HIV-1 RT. AIDS 21: 761-763.
    • (2007) AIDS , vol.21 , pp. 761-763
    • Chappell, B.J.1    Margot, N.A.2    Miller, M.D.3
  • 38
    • 41149145592 scopus 로고    scopus 로고
    • Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
    • Hachiya A, Kodama EN, Sarafianos SG, Schuckmann MM, Sakagami Y, et al. (2008) Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors. J Virol 82: 3261-3270.
    • (2008) J Virol , vol.82 , pp. 3261-3270
    • Hachiya, A.1    Kodama, E.N.2    Sarafianos, S.G.3    Schuckmann, M.M.4    Sakagami, Y.5
  • 39
    • 37849002059 scopus 로고    scopus 로고
    • Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)
    • Shimura K, Kodama E, Sakagami Y, Matsuzaki Y, Watanabe W, et al. (2008) Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137). J Virol 82: 764-774.
    • (2008) J Virol , vol.82 , pp. 764-774
    • Shimura, K.1    Kodama, E.2    Sakagami, Y.3    Matsuzaki, Y.4    Watanabe, W.5
  • 40
    • 0035144979 scopus 로고    scopus 로고
    • Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5)
    • Hachiya A, Aizawa-Matsuoka S, Tanaka M, Takahashi Y, Ida S, et al. (2001) Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5). Antimicrob Agents Chemother 45: 495-501.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 495-501
    • Hachiya, A.1    Aizawa-Matsuoka, S.2    Tanaka, M.3    Takahashi, Y.4    Ida, S.5
  • 41
    • 72149100464 scopus 로고    scopus 로고
    • Mechanism of inhibition of HIV-1 reverse transcriptase by 49-Ethynyl-2-fluoro- 29-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor
    • Michailidis E, Marchand B, Kodama EN, Singh K, Matsuoka M, et al. (2009) Mechanism of inhibition of HIV-1 reverse transcriptase by 49-Ethynyl-2-fluoro- 29-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor. J Biol Chem 284: 35681-35691.
    • (2009) J Biol Chem , vol.284 , pp. 35681-35691
    • Michailidis, E.1    Marchand, B.2    Kodama, E.N.3    Singh, K.4    Matsuoka, M.5
  • 42
    • 34249861631 scopus 로고    scopus 로고
    • Participation of the fingers subdomain of Escherichia coli DNA polymerase I in the strand displacement synthesis of DNA
    • Singh K, Srivastava A, Patel SS, Modak MJ (2007) Participation of the fingers subdomain of Escherichia coli DNA polymerase I in the strand displacement synthesis of DNA. J Biol Chem 282: 10594-10604.
    • (2007) J Biol Chem , vol.282 , pp. 10594-10604
    • Singh, K.1    Srivastava, A.2    Patel, S.S.3    Modak, M.J.4
  • 44
    • 78649659732 scopus 로고    scopus 로고
    • The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine
    • Schuckmann MM, Marchand B, Hachiya A, Kodama EN, Kirby KA, et al. The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine. J Biol Chem.
    • J Biol Chem
    • Schuckmann, M.M.1    Marchand, B.2    Hachiya, A.3    Kodama, E.N.4    Kirby, K.A.5
  • 45
    • 2342453265 scopus 로고    scopus 로고
    • Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir
    • Tuske S, Sarafianos SG, Clark AD, Jr., Ding J, Naeger LK, et al. (2004) Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat Struct Mol Biol 11: 469-474.
    • (2004) Nat Struct Mol Biol , vol.11 , pp. 469-474
    • Tuske, S.1    Sarafianos, S.G.2    Clark Jr., A.D.3    Ding, J.4    Naeger, L.K.5
  • 46
    • 0842289678 scopus 로고    scopus 로고
    • Crystal structures of HIV-1 reverse transcriptases mutated at codons 100, 106 and 108 and mechanisms of resistance to non-nucleoside inhibitors
    • Ren J, Nichols CE, Chamberlain PP, Weaver KL, Short SA, et al. (2004) Crystal structures of HIV-1 reverse transcriptases mutated at codons 100, 106 and 108 and mechanisms of resistance to non-nucleoside inhibitors. J Mol Biol 336: 569-578.
    • (2004) J Mol Biol , vol.336 , pp. 569-578
    • Ren, J.1    Nichols, C.E.2    Chamberlain, P.P.3    Weaver, K.L.4    Short, S.A.5
  • 47
    • 33646749536 scopus 로고    scopus 로고
    • Mutations in Retroviral Genes Associated with Drug Resistance
    • Clark S, Calef C, J M (2006) Mutations in Retroviral Genes Associated with Drug Resistance. HIV Sequence Compendium 2005: 58-175.
    • (2006) HIV Sequence Compendium , vol.2005 , pp. 58-175
    • Clark, S.1    Calef, C.2
  • 48
    • 0032506228 scopus 로고    scopus 로고
    • Unblocking of chainterminated primer by HIV-1 reverse transcriptase through a nucleotidedependent mechanism
    • Meyer PR, Matsuura SE, So AG, Scott WA (1998) Unblocking of chainterminated primer by HIV-1 reverse transcriptase through a nucleotidedependent mechanism. Proc Natl Acad Sci U S A 95: 13471-13476.
    • (1998) Proc Natl Acad Sci U S A , vol.95 , pp. 13471-13476
    • Meyer, P.R.1    Matsuura, S.E.2    So, A.G.3    Scott, W.A.4
  • 49
    • 0037166260 scopus 로고    scopus 로고
    • Primer unblocking and rescue of DNA synthesis by azidothymidine (AZT)- resistant HIV-1 reverse transcriptase: Comparison between initiation and elongation of reverse transcription and between (2) and (+) strand DNA synthesis
    • Rigourd M, Ehresmann C, Parniak MA, Ehresmann B, Marquet R (2002) Primer unblocking and rescue of DNA synthesis by azidothymidine (AZT)- resistant HIV-1 reverse transcriptase: comparison between initiation and elongation of reverse transcription and between (2) and (+) strand DNA synthesis. J Biol Chem 277: 18611-18618.
    • (2002) J Biol Chem , vol.277 , pp. 18611-18618
    • Rigourd, M.1    Ehresmann, C.2    Parniak, M.A.3    Ehresmann, B.4    Marquet, R.5
  • 50
    • 21444443785 scopus 로고    scopus 로고
    • Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase
    • Frankel FA, Marchand B, Turner D, Gotte M, Wainberg MA (2005) Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 49: 2657-2664.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 2657-2664
    • Frankel, F.A.1    Marchand, B.2    Turner, D.3    Gotte, M.4    Wainberg, M.A.5
  • 51
    • 42649118796 scopus 로고    scopus 로고
    • Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data
    • Winters B, Montaner J, Harrigan PR, Gazzard B, Pozniak A, et al. (2008) Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data. J Acquir Immune Defic Syndr 48: 26-34.
    • (2008) J Acquir Immune Defic Syndr , vol.48 , pp. 26-34
    • Winters, B.1    Montaner, J.2    Harrigan, P.R.3    Gazzard, B.4    Pozniak, A.5
  • 52
    • 69949166547 scopus 로고    scopus 로고
    • A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype
    • Van Houtte M, Picchio G, Van Der Borght K, Pattery T, Lecocq P, et al. (2009) A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype. J Med Virol 81: 1702-1709.
    • (2009) J Med Virol , vol.81 , pp. 1702-1709
    • van Houtte, M.1    Picchio, G.2    van der Borght, K.3    Pattery, T.4    Lecocq, P.5
  • 53
    • 41849113448 scopus 로고    scopus 로고
    • National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutation
    • Delaugerre C, Flandre P, Marcelin AG, Descamps D, Tamalet C, et al. (2008) National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutation. J Med Virol 80: 762-765.
    • (2008) J Med Virol , vol.80 , pp. 762-765
    • Delaugerre, C.1    Flandre, P.2    Marcelin, A.G.3    Descamps, D.4    Tamalet, C.5
  • 54
    • 34250203926 scopus 로고    scopus 로고
    • Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase
    • Kagan RM, Lee TS, Ross L, Lloyd RM, Jr., Lewinski MA, et al. (2007) Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase. Antiviral Res 75: 210-218.
    • (2007) Antiviral Res , vol.75 , pp. 210-218
    • Kagan, R.M.1    Lee, T.S.2    Ross, L.3    Lloyd Jr., R.M.4    Lewinski, M.A.5
  • 55
    • 33845997466 scopus 로고    scopus 로고
    • Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors
    • Sluis-Cremer N, Sheen CW, Zelina S, Torres PS, Parikh UM, et al. (2007) Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother 51: 48-53.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 48-53
    • Sluis-Cremer, N.1    Sheen, C.W.2    Zelina, S.3    Torres, P.S.4    Parikh, U.M.5
  • 56
    • 34548313857 scopus 로고    scopus 로고
    • Mutations at 65 and 70 within the context of a Q151M cluster in human immunodeficiency virus type 1 reverse transcriptase impact the susceptibility to the different nucleoside reverse transcriptase inhibitors in distinct ways
    • Van Laethem K, Pannecouque C, Vandamme AM (2007) Mutations at 65 and 70 within the context of a Q151M cluster in human immunodeficiency virus type 1 reverse transcriptase impact the susceptibility to the different nucleoside reverse transcriptase inhibitors in distinct ways. Infect Genet Evol 7: 600-603.
    • (2007) Infect Genet Evol , vol.7 , pp. 600-603
    • van Laethem, K.1    Pannecouque, C.2    Vandamme, A.M.3
  • 57
    • 0024310253 scopus 로고
    • Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)
    • Larder BA, Kemp SD (1989) Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246: 1155-1158.
    • (1989) Science , vol.246 , pp. 1155-1158
    • Larder, B.A.1    Kemp, S.D.2
  • 59
    • 42149127570 scopus 로고    scopus 로고
    • Gln151 of HIV-1 reverse transcriptase acts as a steric gate towards clinically relevant acyclic phosphonate nucleotide analogues
    • Frangeul A, Bussetta C, Deval J, Barral K, Alvarez K, et al. (2008) Gln151 of HIV-1 reverse transcriptase acts as a steric gate towards clinically relevant acyclic phosphonate nucleotide analogues. Antivir Ther 13: 115-124.
    • (2008) Antivir Ther , vol.13 , pp. 115-124
    • Frangeul, A.1    Bussetta, C.2    Deval, J.3    Barral, K.4    Alvarez, K.5
  • 60
    • 33751401607 scopus 로고    scopus 로고
    • Site-directed mutagenesis in the fingers subdomain of HIV-1 reverse transcriptase reveals a specific role for the beta3-beta4 hairpin loop in dNTP selection
    • Garforth SJ, Kim TW, Parniak MA, Kool ET, Prasad VR (2007) Site-directed mutagenesis in the fingers subdomain of HIV-1 reverse transcriptase reveals a specific role for the beta3-beta4 hairpin loop in dNTP selection. J Mol Biol 365: 38-49.
    • (2007) J Mol Biol , vol.365 , pp. 38-49
    • Garforth, S.J.1    Kim, T.W.2    Parniak, M.A.3    Kool, E.T.4    Prasad, V.R.5
  • 61
    • 0029038744 scopus 로고
    • Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptase
    • Sarafianos SG, Pandey VN, Kaushik N, Modak MJ (1995) Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptase. Biochemistry 34: 7207-7216.
    • (1995) Biochemistry , vol.34 , pp. 7207-7216
    • Sarafianos, S.G.1    Pandey, V.N.2    Kaushik, N.3    Modak, M.J.4
  • 62
    • 35948991804 scopus 로고    scopus 로고
    • In vitro suppression of K65R reverse transcriptase-mediated tenofovir- and adefovir-59-diphosphate resistance conferred by the boranophosphonate derivatives
    • Frangeul A, Barral K, Alvarez K, Canard B (2007) In vitro suppression of K65R reverse transcriptase-mediated tenofovir- and adefovir-59-diphosphate resistance conferred by the boranophosphonate derivatives. Antimicrob Agents Chemother 51: 3162-3167.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 3162-3167
    • Frangeul, A.1    Barral, K.2    Alvarez, K.3    Canard, B.4
  • 63
    • 0029112612 scopus 로고
    • Site-directed mutagenesis of arginine 72 of HIV-1 reverse transcriptase. Catalytic role and inhibitor sensitivity
    • Sarafianos SG, Pandey VN, Kaushik N, Modak MJ (1995) Site-directed mutagenesis of arginine 72 of HIV-1 reverse transcriptase. Catalytic role and inhibitor sensitivity. J Biol Chem 270: 19729-19735.
    • (1995) J Biol Chem , vol.270 , pp. 19729-19735
    • Sarafianos, S.G.1    Pandey, V.N.2    Kaushik, N.3    Modak, M.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.